A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer - Concepedia

Concepedia

Publication | Closed Access

A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer

29

Citations

27

References

2015

Year

Analía Azaro, Jordi Rodón, Antonio Calles, Irene Braña, Manuel Hidalgo, Pedro P. López‐Casas, Manuel Muñoz, Paul Westwood, J. A. Miller, Brian A. Moser,

Investigational New Drugs

Akt InhibitorFirst-in-human PhaseMedicinePathologyImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyMetastatic Cancer

References

	Year	Citations

Page 1

Page 1